Genome Map of Multiple Myeloma Offers Clues to Its Cause
Scientist says effort may lead to new ways to treat the blood cancer
WEDNESDAY, March 23 (HealthDay News) -- The genome of the highly aggressive blood cancer multiple myeloma has been mapped by a team of North American scientists, who say their achievement will improve understanding of what causes the disease and may lead to new treatments.
"For the first time, we are able to see on a molecular basis what might be causing this malignancy," Dr. David S. Siegel, chief of the multiple myeloma division at the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey, said in a news release from the center.
"We already know what causes many types of cancer, but until now, we had few clues to the causes of myeloma," he added.
He and colleagues from 20 major research institutions examined genomes of both tumor and normal blood cells in 38 people with multiple myeloma.
"We have developed the most comprehensive molecular picture of myeloma to date, which will provide a public resource of genomic information for this disease," Siegel said. "This is a large step forward in personalized medicine for the treatment of multiple myeloma. My hope is that this will allow us to develop more targeted, effective therapies."
Their findings are reported in the March 24 issue of Nature.
The American Cancer Society has more about multiple myeloma.Robert Preidt SOURCE: John Theurer Cancer Center, news release, March 23, 2011 Related Articles
- Groups Call for Medicare Coverage of Lung Cancer Screening
September 30, 2014
- Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors
September 30, 2014
Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.
Copyright © 2011 HealthDay. All rights reserved.